Clinical Trial Update: BF844 Safety and Pharmacokinetic Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of BF844 in healthy volunteers, sponsored by EyeXCel Pty. Ltd., with Usher syndrome type 3 listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Usher Syndrome Type

Drugs mentioned

• BF844

Snippet

Sponsor: EyeXCel Pty. Ltd. | Conditions: Usher Syndrome Type 3 | Phase 1 | Status: NOT_YET_RECRUITING